Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17607120 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Procedure: adjuvant therapy

Indicates status has not been verified in more than two years